within Pharmacolibrary.Drugs.ATC.G;

model G03AC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01,
    Tlag           = 1800
  );

  annotation(Documentation(
    info ="<html><body><p>Lynestrenol is a synthetic progestogen (progestin) formerly used for contraception, treatment of menstrual disorders, and certain gynecological conditions. It is a 19-nortestosterone derivative and functions primarily by suppressing ovulation and altering endometrial structure. Its clinical use has largely been discontinued in most countries and it is rarely used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters here are estimates for healthy adult women, as there is a lack of published compartmental PK models or explicit PK parameter reports for lynestrenol. Values are inferred based on related progestogens and available summary data.</p><h4>References</h4><ol><li><p>Orme, ML, et al., &amp; Breckenridge, AM (1983). Clinical pharmacokinetics of oral contraceptive steroids. <i>Clinical pharmacokinetics</i> 8(2) 95–136. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198308020-00001&quot;>10.2165/00003088-198308020-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6342899/&quot;>https://pubmed.ncbi.nlm.nih.gov/6342899</a></p></li><li><p>Yasuda, J, et al., &amp; Okada, H (1981). [Pharmacokinetics of norethindrone and lynestrenol studied by HPLC (author&#x27;s transl)]. <i>Nihon Naibunpi Gakkai zasshi</i> 57(8) 1159–1166. DOI:<a href=&quot;https://doi.org/10.1507/endocrine1927.57.8_1159&quot;>10.1507/endocrine1927.57.8_1159</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7319102/&quot;>https://pubmed.ncbi.nlm.nih.gov/7319102</a></p></li><li><p>Kuhl, H (1990). Pharmacokinetics of oestrogens and progestogens. <i>Maturitas</i> 12(3) 171–197. DOI:<a href=&quot;https://doi.org/10.1016/0378-5122(90)90003-o&quot;>10.1016/0378-5122(90)90003-o</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2170822/&quot;>https://pubmed.ncbi.nlm.nih.gov/2170822</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03AC02;
